Brain and Spine Center of Texas, Plano, Texas 75093, USA.
J Neurosurg Spine. 2011 Feb;14(2):244-9. doi: 10.3171/2010.9.SPINE09828. Epub 2010 Dec 24.
The goal of this study was to demonstrate the incidence of fusion and soft-tissue swelling in multilevel anterior cervical discectomies and fusions (ACDFs) using polyetheretherketone (PEEK) spacers with recombinant human bone morphogenetic protein-2 (rhBMP-2) impregnated in a Type I collagen sponge and titanium plates.
A single surgeon performed 30 multilevel ACDFs using PEEK spacers with an rhBMP-2 impregnated collagen sponge (0.4 ml, or the equivalent of 0.6 mg rhBMP-2). Soft-tissue swelling was assessed using cervical spine radiographs on postoperative Day 1 and at 2, 6, and 10 weeks and 6 months after surgery. Incidence of dysphagia was assessed with the Cervical Spine Research Society Swallowing-Quality of Life tool. Clinical success was evaluated with the Neck Disability Index, neck pain scores, and arm pain scores. Final fusion was assessed with CT by an independent neuroradiologist.
Patients were followed for 6 months unless they had an incomplete fusion; those patients were reassessed at 9 months. Twenty-four patients underwent 2-level ACDFs and 6 underwent 3-level ACDFs were performed on patients with the following risk factors for pseudarthrosis: smoking (33%), diabetes (13%), and obesity (body mass index ≥ 30 [43%]). Seventeen percent of the patients had multiple risk factors. Soft-tissue swelling peaked at 2 weeks regardless of level of surgery or number of levels treated surgically and decreased to near preoperative levels by 6 months. At 2 weeks, Swallowing-Quality of Life evaluation showed 19% of patients frequently choking on food, 4.8% frequently choking when drinking, and 47.6% with frequent food sticking in the throat. Scores continued to improve, and at 6 months, 0% had frequent choking on food, 6.7% had frequent difficulty drinking, and 6.7% had frequent food sticking in the throat. The Neck Disability Index, neck pain, and arm pain scores all improved progressively over 6 months. Incidence of fusion was 95% at 6 months and 100% at 9 months. There were no rehospitalizations or reoperations for soft-tissue swelling or dysphagia.
Multilevel ACDF procedures using PEEK grafts and rhBMP-2 can be performed safely in patients with multiple risk factors for pseudarthrosis with excellent fusion outcomes.
本研究旨在展示使用聚醚醚酮(PEEK)椎间融合器联合重组人骨形态发生蛋白-2(rhBMP-2)复合Ⅰ型胶原海绵及钛板行前路颈椎间盘切除融合术(ACDF)治疗多节段颈椎疾病的融合率和软组织肿胀情况。
单名外科医生为 30 例患者施行多节段 ACDF 手术,使用 PEEK 椎间融合器联合 rhBMP-2 复合Ⅰ型胶原海绵(0.4ml,或相当于 0.6mg rhBMP-2)。术后第 1 天、2 周、6 周、10 周及 6 个月拍摄颈椎侧位片评估软组织肿胀情况。采用颈椎研究协会吞咽生活质量量表评估吞咽困难的发生率。采用颈椎残障指数(NDI)、颈部疼痛评分和手臂疼痛评分评估临床疗效。术后 6 个月时采用 CT 由独立神经放射科医生评估终板融合情况。
24 例患者接受 2 节段 ACDF 手术,6 例患者接受 3 节段 ACDF 手术。这些患者存在骨不连的高危因素,包括吸烟(33%)、糖尿病(13%)和肥胖(体重指数≥30kg/m2,占 43%)。17%的患者存在多种高危因素。无论手术节段数或治疗节段数如何,术后 2 周软组织肿胀均达高峰,6 个月时肿胀接近术前水平。术后 2 周,吞咽生活质量量表评估显示 19%的患者经常被食物噎到,4.8%经常在饮水时呛到,47.6%经常感觉食物卡在喉咙里。评分持续改善,术后 6 个月时,0%的患者经常被食物噎到,6.7%经常在饮水时呛到,6.7%经常感觉食物卡在喉咙里。术后 6 个月,NDI、颈部疼痛和手臂疼痛评分均持续改善。术后 6 个月融合率为 95%,术后 9 个月融合率为 100%。无因软组织肿胀或吞咽困难再次住院或手术的病例。
在存在多种骨不连高危因素的患者中,多节段 ACDF 手术联合 PEEK 移植物和 rhBMP-2 治疗可安全进行,融合效果极佳。